Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL9 | O00512 | 1/20 | 0.74 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.74 |
| ▸ | HTR2A | P28223 | 1/20 | 0.53 |
| ▸ | MGLL | Q99685 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.43 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.43 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29189078 | 0.91 | BCL9 (0.59) | BCL9CTNNB1HTR2AMGLLGAA | |
| SCHEMBL6395955 | 0.91 | BCL9 (0.60) | BCL9CTNNB1HTR2AMGLLGAA | |
| SCHEMBL6444724 | 0.90 | BCL9 (0.59) | BCL9CTNNB1HTR2AMGLLGAA | |
| SCHEMBL31629546 | 0.90 | BCL9 (0.59) | BCL9CTNNB1HTR2AMGLLGAA | |
| SCHEMBL31331481 | 0.90 | BCL9 (0.59) | BCL9CTNNB1HTR2AMGLLGAA | |
| SCHEMBL5762656 | 0.89 | BCL9 (0.60) | BCL9CTNNB1HTR2AMGLLGAA | |
| SCHEMBL15548469 | 0.88 | BCL9 (0.56) | BCL9CTNNB1HTR2AMGLLGAA | |
| SCHEMBL29189081 | 0.86 | BCL9 (0.54) | BCL9CTNNB1HTR2AMGLLGAA | |
| SCHEMBL133257 | 0.85 | BCL9 (1.00) | BCL9CTNNB1HTR2AMGLLGAA | |
| SCHEMBL3468592 | 0.84 | HTR2A (0.56) | BCL9CTNNB1HTR2AMGLLGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040176350-A1 | Carbapenem compound | KYOTO PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2004-09-09 | — | — | US | disclosed |
| EP-1398314-A1 | CARBAPENEM COMPOUND | Kyoto Pharmaceutical Industries, Ltd. (JP) | 2004-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176350-A1 | Carbapenem compound | ALPI, SI, OXA1L | BCL9 1306/4885CTNNB1 56/4885HTR2A 4776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.